Babson Diagnostics
Latest round
- Series B
Last raised
- Jun 2021
Total raised
- $45M
Investors
- 5
About Babson Diagnostics
, based in the US, specializes in innovative blood testing technology designed to enhance patient access and convenience in healthcare services.Founded in 2017 and headquartered in Austin, TX, Babson Diagnostics, Inc. aims to redefine blood testing with its advanced technology.Babson Diagnostics specializes in innovative blood testing solutions designed to provide convenient and accessible healthcare services to patients. Their flagship product, the BetterWay technology, enables accurate blood testing using a small sample—essentially a pea-sized amount of blood collected via a finger prick. This technology is clinically validated through rigorous studies, emphasizing accuracy and reliability. Babson's services target consumers who seek a more patient-centric approach to blood testing, allowing them to obtain essential health insights at local pharmacies.The revenue model for Babson Diagnostics revolves around partnerships with healthcare providers and local pharmacies, facilitating direct-to-consumer blood testing services. Clients, which include healthcare practitioners and retail pharmacies, engage with Babson to provide their patients with easy access to blood testing. Transactions are structured as service fees charged for individual tests conducted through the BetterWay platform, which may be facilitated by healthcare professionals ordering tests on behalf of their patients. The pricing structure for these services reflects the cost of innovation and convenience, ensuring that patients receive medically accurate results without the need for extensive blood draws.In October 2024, Babson Diagnostics, Inc. Babson is strategizing to expand its market presence, focusing on new geographic regions to enhance its service delivery, although specific regions and product launch dates have not been disclosed.
Who invested in Babson Diagnostics
5 investors across 2 rounds
See all investors in Babson Diagnostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Babson Diagnostics
Who invested in Babson Diagnostics?
Babson Diagnostics has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Babson Diagnostics raised?
Babson Diagnostics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Babson Diagnostics last raise money?
Babson Diagnostics's most recent round on record is a Series B, in Jun 2021.
What does Babson Diagnostics do?
, based in the US, specializes in innovative blood testing technology designed to enhance patient access and convenience in healthcare services.
Where is Babson Diagnostics headquartered?
Babson Diagnostics is headquartered in Austin, US.
Which VCs invest in companies like Babson Diagnostics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Babson Diagnostics's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Babson Diagnostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.